⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OCGN News
Ocugen, Inc. Common Stock
Form 8-K
sec.gov
OCGN
Form 8-K
sec.gov
OCGN
Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
OCGN
Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
OCGN
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
prnewswire.com
NAGE
OCGN
NTLA
GERN
Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa
globenewswire.com
OCGN
ODIN SafeWave EMF Blocking Sticker Review 2026: Don't Buy Without Reading This First!
accessnewswire.com
OCGN
Ocugen to Host Conference Call on Wednesday, March 4, 2026 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
OCGN
Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer
globenewswire.com
OCGN
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock
globenewswire.com
OCGN